Synthesis of Injectable Alginate Hydrogels with Muscle-Derived Stem Cells for Potential Myocardial Infarction Repair
Open Access
- 4 March 2017
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 7 (3) , 252
Abstract
Myocardial infarction (MI), caused by the occlusion of the left ventricular coronary artery, leads to the loss of cardiomyocytes and, potentially, heart failure. Cardiomyocytes in adult mammals proliferate at an extremely low rate and thus, a major challenge in MI treatment is supplementing exogenous cells and keeping them viable in MI areas. To address this challenge, injecting hydrogels encapsulating cells into MI areas, to compensate for the loss of cardiomyocytes, shows promise. This study synthesized two types of alginate hydrogels, based on self-crosslinking (SCL) and calcium ion crosslinking (Ca2+) in varying formulations. The hydrogels encapsulated living muscle-derived stem cells (MDSCs) and their performance was evaluated in terms of optimizing cell viability during the injection process, as well as the live/dead rate after long-term cultivation. The morphology of the hydrogel-encapsulated cells was characterized by scanning electronic microscopy (SEM) and live/dead cells were examined using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide staining) assay. The mechanical properties of the hydrogels were also determined via a rheometer, to identify their influence on cell viability during the injection process and with respect to long-term cultivation. The SCL hydrogel with a 0.8% alginate and 20% gelatin formulation resulted in the highest cell viability during the injection process, and the Ca2+ hydrogel composed of 1.1% alginate and 20% gelatin maintained the highest cell survival rate after two months in culture.Keywords
This publication has 35 references indexed in Scilit:
- Cardiac Stem Cell Treatment in Myocardial InfarctionCirculation Research, 2016
- Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2016
- Executive Summary: Heart Disease and Stroke Statistics—2016 UpdateCirculation, 2016
- Engineering Angiogenesis for Myocardial Infarction Repair: Recent Developments, Challenges, and Future DirectionsCardiovascular Engineering and Technology, 2014
- A strategy for fabrication of a three-dimensional tissue construct containing uniformly distributed embryoid body-derived cells as a cardiac patchBiomaterials, 2010
- Cell-Induced Alignment Augments Twitch Force in Fibrin Gel–Based Engineered Myocardium via Gap Junction ModificationTissue Engineering Part A, 2009
- Functional Improvement of Infarcted Heart by Co-Injection of Embryonic Stem Cells with Temperature-Responsive Chitosan HydrogelTissue Engineering Part A, 2009
- Stem Cells for Heart Cell TherapiesTissue Engineering Part B: Reviews, 2008
- Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repairBiomaterials, 2008
- Evidence That Human Cardiac Myocytes Divide after Myocardial InfarctionNew England Journal of Medicine, 2001